|FORM 3||UNITED STATES SECURITIES AND EXCHANGE COMMISSION|
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|Expires:||December 31, 2014|
|Estimated average burden|
|hours per response||0.5|
|1. Name and Address of Reporting Person*|
|C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVENUE|
|2. Date of Event Requiring Statement (Month/Day/Year)|
|3. Issuer Name and Ticker or Trading Symbol |
|4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|X||Officer (give title below)||Other (specify below)|
|EVP, Sales and Marketing||5. If Amendment, Date of Original Filed (Month/Day/Year)|
|6. Individual or Joint/Group Filing (Check Applicable Line)
|X||Form filed by One Reporting Person|
|Form filed by More than One Reporting Person|
|Table I - Non-Derivative Securities Beneficially Owned|
|1. Title of Security (Instr.
Amount of Securities Owned (Instr.
||3. Ownership Form: Direct (D) or Indirect (I) (Instr.
||4. Nature of Indirect Beneficial Ownership (Instr.
No securities owned
|Table II - Derivative Securities Beneficially Owned|
(e.g., puts, calls, warrants, options, convertible securities)
|1. Title of Derivative Security (Instr. 4) ||2. Date Exercisable and Expiration Date (Month/Day/Year)
||3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)||4. Conversion or Excercise Price of Derivative Security
||5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)
||6. Nature of Indirect Beneficial Ownership (Instr. 5)
|Date Exercisable||Expiration Date||Title||Amount or Number of Shares|
Employee Stock Option (Right to Buy)
|Explanation of Responses:|
|/s/ Rainer M. Erdtmann, Attorney-in-fact||07/30/2012|
|** Signature of Reporting Person||Date|
|Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.|
|* If the form is filed by more than one reporting person, see Instruction 5(b)(v).|
|** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see Instruction 6 for procedure.|
|Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.|
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby authorizes Robert W.
Duggan and Rainer M. Erdtmann of Pharmacyclics, Inc. (the "Company"), to execute
for and on behalf of the undersigned, in the undersigned's capacity as an
officer of the Company, Forms 3, 4 and 5, and any amendments thereto, and cause
such form(s) to be filed with the United States Securities and Exchange
Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to
the undersigned's beneficial ownership of securities in the Company. The
undersigned hereby grants to each such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact,
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of, and transactions in, securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing delivered
to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this July 27, 2012.
/s/ Paula S. Sjovall Boultbee
Paula S. Sjovall Boultbee